QY Research, Inc.

Global Venous Thromboembolism Vte Therapeutics Market Industry Trend and Forecast 2025

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.


City of Industry, CA -- (SBWIRE) -- 08/16/2018 -- This report studies the global market size of Venous thromboembolism(VTE)Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Venous thromboembolism(VTE)Therapeutics in these regions.
This research report categorizes the global Venous thromboembolism(VTE)Therapeutics market by top players/brands, region, type and end user. This report also studies the global Venous thromboembolism(VTE)Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE

One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Boehringer Ingelheim



Bristol-Myers Squibb



Portola Pharmaceuticals


Market size by Product

Deep Vein Thrombosis(DVT)

Pulmonary Embolism(PE)


Market size by End User



Research Institutes

Market size by Region

North America

United States







South Korea















Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

The study objectives of this report are:

To study and analyze the global Venous thromboembolism(VTE)Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To understand the structure of Venous thromboembolism(VTE)Therapeutics market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Venous thromboembolism(VTE)Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Venous thromboembolism(VTE)Therapeutics submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Venous thromboembolism(VTE)Therapeutics are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/aec57e047a27461577c5948b873fea65,0,1

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Venous thromboembolism(VTE)Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/659934/global-venous-thromboembolism-vte-therapeutics-market

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.